PET-Scans Not as Specific for Richters Transformation  Biopsies are essential for those who fail new therapies

PET-Scans Not as Specific for Richters Transformation Biopsies are essential for those who fail new therapies

hematologydebates

1 year
28 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Jose F. Leis, MD, PhD, explains PET-Scans Not as Specific for Richter's Transformation Biopsies are essential for those who fail new therapies at Imedex Great Debates 2018.
Up Next Autoplay
Incorporating Different Schedules into Combinations  Use minimum active dose
Incorporating Different Schedules into Combinations Use minimum active dose
Category: Hematologic Malignancies
298 Views
hematologydebates 1 year
Quadruple Agents in Relapse Refractory Myeloma  Capitalizing on synergy & lack of toxicities
Quadruple Agents in Relapse Refractory Myeloma Capitalizing on synergy & lack of toxicities
Category: Hematologic Malignancies
232 Views
hematologydebates 1 year
Adding to Lenalidomide to Make it Work Better  Prednisone inhibitors, carfilzomib, and bortezomib
Adding to Lenalidomide to Make it Work Better Prednisone inhibitors, carfilzomib, and bortezomib
Category: Hematologic Malignancies
202 Views
hematologydebates 1 year
One Size Does Not Fit All in Myeloma   Clonal Tiding & Complex Heterogeneity
One Size Does Not Fit All in Myeloma Clonal Tiding & Complex Heterogeneity
Category: Hematologic Malignancies
262 Views
hematologydebates 1 year
Early Transplant Confers PFS Benefit, but Not Overall  Stem cell transplant is an option
Early Transplant Confers PFS Benefit, but Not Overall Stem cell transplant is an option
Category: Hematologic Malignancies
186 Views
hematologydebates 1 year
Combinations with RVD Beyond Daratumumab  Data with ixazomib, revlimid, & dexamethasone
Combinations with RVD Beyond Daratumumab Data with ixazomib, revlimid, & dexamethasone
Category: Hematologic Malignancies
190 Views
hematologydebates 1 year
RVD-Lite Mission Treating Over 50 Patients Regimen of Bortezomib, lenalidomide, steroids
RVD-Lite Mission Treating Over 50 Patients Regimen of Bortezomib, lenalidomide, steroids
Category: Hematologic Malignancies
51 Views
hematologydebates 1 year
Selinexor is a Novel Mechanism of Action  Venetoclax Serves a Challenging Population
Selinexor is a Novel Mechanism of Action Venetoclax Serves a Challenging Population
Category: Chronic Lymphocytic Leukemia
140 Views
hematologydebates 1 year
Role of Venetoclax in Plasma Cell Leukemia Excellent partner drug with non-overlapping toxicities
Role of Venetoclax in Plasma Cell Leukemia Excellent partner drug with non-overlapping toxicities
Category: Chronic Lymphocytic Leukemia
110 Views
hematologydebates 1 year
Powerful new IMiDs, CC-220 & CC-92480 Importance of Small Molecules in advanced trials
Powerful new IMiDs, CC-220 & CC-92480 Importance of Small Molecules in advanced trials
Category: Chronic Lymphocytic Leukemia
253 Views
hematologydebates 1 year